The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.
Personal data of nearly half of the popular genetic testing company's customers -- 6.9 million people -- was exposed in the data breach. If you were one of these victims, you could be in-line for a ...
After a data breach affected around half of its customers, family ancestry company 23andMe has agreed to a $30 million settlement — and users could be eligible to receive a payout in the future.
As the company restructures, it will pivot to selling genetic tests to consumers and using that data for research. Also: medicinal and tech advancements in cancer care; research monkeys roundup.